Chemed Corp
Change company Symbol lookup
Select an option...
CHE Chemed Corp
SIRI Sirius XM Holdings Inc
CTS CTS Corp
NSRCF NextSource Materials Inc
GDSI Global Digital Solutions Inc
TRCTF Traction Uranium Corp
TWNK Hostess Brands Inc
APLD Applied Blockchain Inc
STEW SRH Total Return Fund, Inc
AUTO Autoweb Inc
Go

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

Chemed Corporation is focused on purchasing, operating, and divests subsidiaries in diverse business activities. The Company’s segments include VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The Company's VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Company services are provided through a network of Company-owned branches, independent contractors, and franchisees. The Company operates through its two wholly owned subsidiaries VITAS Healthcare Corporation and Roto-Rooter Group, Inc.

Closing Price
$478.25
Day's Change
5.84 (1.24%)
Bid
--
Ask
--
B/A Size
--
Day's High
479.44
Day's Low
469.11
Volume
(Light)
Volume:
40,542

10-day average volume:
74,801
40,542

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CDNA, APPS and YEXT

1:01 pm ET June 28, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / June 28, 2022 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

CareDx, Inc. (NASDAQ:CDNA)

This lawsuit is on behalf of all persons or entities who purchased CareDx common stock between February 24, 2021, and May 5, 2022.

A class action has commenced on behalf of certain shareholders in CareDx, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) defendants had engaged in a variety of improper and illegal schemes to inflate testing services revenue and demand, including pushing a surveillance protocol through inaccurate marketing materials, offering extravagant inducements or kickbacks to physicians and other providers, and improperly bundling expensive testing services with other blood tests as part of the Company's RemoTraC service for remote, home-based, blood-drawing; (2) these practices, and others, subjected CareDx to an undisclosed risk of regulatory scrutiny; (3) these practices rendered the Company's testing services revenue reported throughout the class period artificially inflated; and (4) as a result, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/caredx-inc-loss-submission-form/?id=29305&from=1

Digital Turbine, Inc. (NASDAQ:APPS)

Investors Affected : August 9, 2021 - May 17, 2022

A class action has commenced on behalf of certain shareholders in Digital Turbine, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's recent acquisitions, AdColony and Fyber, act as agents in certain of their respective product lines; (2) as a result, revenues for those product lines must be reported net of license fees and revenue share, rather than on a gross basis; (3) the Company's internal control over financial reporting as to revenue recognition was deficient; and (4) as a result of the foregoing, the Company's net revenues was overstated throughout fiscal 2022; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/digital-turbine-inc-loss-submission-form/?id=29305&from=1

Yext, Inc. (NYSE:YEXT)

Investors Affected : March 4, 2021 - March 8, 2022

A class action has commenced on behalf of certain shareholders in Yext, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Yext's revenue and earnings were significantly deteriorating because of, among other things, poor sales execution and performance, as well as COVID-19 related disruptions; (ii) accordingly, Yext was unlikely to meet consensus estimates for its full year fiscal 2022 financial results and fiscal 2023 outlook; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/yext-class-action-lawsuit/?id=29305&from=1

The Gross Law Firm, Tuesday, June 28, 2022, Press release picture

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm

15 West 38th Street, 12th floor

New York, NY, 10018

Email: dg@securitiesclasslaw.com

Phone: (212) 537-9430

Fax: (833) 862-7770

SOURCE : The Gross Law Firm





View source version on accesswire.com:

https://www.accesswire.com/706800/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-CDNA-APPS-and-YEXT



comtex tracking

COMTEX_409382024/2457/2022-06-28T13:01:06

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.